Nocturia: New directions

Neurourology and Urodynamics

Volumn 30, Issue 5, 2011, Pages 700-703

  Weiss, Jeffrey P ^a   Wein, Alan J ^a   Van Kerrebroeck, Philip ^a   Dmochowski, Roger ^a   Fitzgerald, Marypat ^a   Tikkinen, Kari A O ^a   Abrams, Paul ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Future research; Lower urinary tract symptoms; Nocturia; Quality of life

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIDIURETIC AGENT; DESMOPRESSIN; MUSCARINIC RECEPTOR BLOCKING AGENT; PLACEBO; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; STEROID 5ALPHA REDUCTASE INHIBITOR;

BEHAVIOR MODIFICATION; BLADDER CAPACITY; BOTHERSOMENESS; COMORBIDITY; DISEASE CLASSIFICATION; DISEASE SEVERITY; ECONOMIC ASPECT; HUMAN; HYPONATREMIA; LOWER URINARY TRACT SYMPTOM; MEDICAL RESEARCH; MEDICAL SOCIETY; NOCTURIA; POSITIVE END EXPIRATORY PRESSURE; PREVALENCE; QUALITY OF LIFE; REVIEW; SLEEP APNEA SYNDROME; SLEEP DEPRIVATION; TRANSURETHRAL RESECTION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANIMALS; BIOMEDICAL RESEARCH; COST OF ILLNESS; HEALTH CARE COSTS; HUMANS; NOCTURIA; PREVALENCE; QUALITY OF LIFE; TERMINOLOGY AS TOPIC; TREATMENT OUTCOME;

EID: 79959818924     PISSN: 07332467     EISSN: 15206777     Source Type: Journal    
DOI: 10.1002/nau.21125     Document Type: Review

References (40)

1. van Kerrebroeck P, Abrams P, Chaikin D, et al. Standardisation of terminology of nocturia. Neurourol Urodyn 2002;21:179-83.
2. Weber AM, Abrams P, Brubaker L, et al. The standardization of terminology for researchers in female pelvic floor disorders. Int Urogynecol J 2001;12:178-86. (Pubitemid 32611453)
3. Lee CL, Weiss JP, Blaivas JG. Nocturia: Diagnosis and management. In: Staskin DS, editor. Atlas of bladder disease. Philadelphia: Current Medicine Group; 2009; pp 23-34.
4. Norgaard JP, Hashim H, Malmberg L, et al. Antidiuresis therapy: Mechanism of action and clinical implications. Neurourol Urodyn 2007;26:1008-13. (Pubitemid 350085902)
5. Weiss JP, Blaivas JG. Nocturia. J Urol 2000;163:5-12.
6. Tikkinen KAO, Johnson TM, Tammela RLJ, et al. Nocturia frequency, bother and quality of life: How often is too often? A population-based study in Finland. Eur Urol 2010;57:488-98.
7. Sintonen H. The 15D instrument of health-related quality of life: Properties and applications. Ann Med 2001;33:328-36. (Pubitemid 32675373)
8. Buysse DJ, Reynolds CF, Monk TA, et al. The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiat Res 1989;28:193-213. (Pubitemid 19144991)
9. Abraham L, Hareendran A, Mills IW, et al. Development and validation of a quality-of-life measure for men with nocturia. Urology 2004;63:481-6.
10. Bing MH, Moller LA, Jennum P, et al. Validity and reliability of a questionnaire for evaluating nocturia, nocturnal enuresis and sleep-interruptions in an elderly population. Eur Urol 2006;49:710-9. (Pubitemid 43374737)
11. Tikkinen KAO, Tammela TLJ, Huhtala H, et al. Is nocturia equally common among men and women? A population based study in Finland. J Urol 2006;175:596-600. (Pubitemid 43067379)
12. Schatzyl G, Temml C, Schmidauer J, et al. Cross sectional study of nocturia in both sexes: Analysis of a voluntary health screening project. Urology 2000;56:71-5. (Pubitemid 30408657)
13. Yu HJ, Chen FY, Huang PC, et al. Impact of nocturia on symptom-specific quality of life among community-dwelling adults aged 40 years and older. Urology 2006;67:713-8.
14. Kobelt G, Borgström F, Mattiasson A. Productivity, vitality and utility in a group of healthy professionally active individuals with nocturia. BJU Int 2003;91:190-5. (Pubitemid 36232833)
15. Holm-Larsen T, Weiss JP, Langkilde LK. Economic burden of nocturia in the US adult population. J. Urol 2010;183(4): Supplement, Page e1.
16. Stewart RB, Moore MT, May FE, et al. Nocturia: A risk factor for falls in the elderly. J Am Geriatr Soc 1992;40:1217-20.
17. Kupelian V, Fitzgerald MP, Kaplan SA, et al. Association of nocturia and mortality: Results from the Third National Health and Nutrition Examination Survey. J Urol 2011;185(2): 571-7.
18. Nakagawa H, Niu K, Kaiho Y, et al. Mortality in the elderly correlates with the frequency of nighttime voiding: Results of a 3-year prospective cohort study in Japan. J Urol Suppl 2010;181:e1, abstract 3.
19. Fitzgerald MP, Litman HJ, Link CL, et al. The association of nocturia with cardiac disease, diabetes, body mass index, age and diuretic use: Results from the BACH survey. J Urol 2007;177:1385-9. (Pubitemid 46436009)
20. Häkkinen JT, Shiri R, Koskimäki J, et al. Depressive symptoms increase the incidence of nocturia: Tampere Aging Male Urologic Study (TAMUS). J Urol 2008;179:1897-901.
21. Brubaker L, Fitzgerald MP. Nocturnal polyuria and nocturia relief in patients treated with solifenacin for overactive bladder symptoms. Int Urogynecol J 2007;18:737-41. (Pubitemid 47023322)
22. Cardozo L. Lisec M, Millard R, et al. Randomized, double-blind placebo controlled trial of the once daily antimuscarinic agent solifenacin succinate in patients with overactive bladder. J Urol 2004;172:1919-24. (Pubitemid 39363090)
23. Dmochowski R, Peters K, Morrow J, et al. Randomized, double-blind, placebo-controlled trial of flexible-dose fesoterodine in subjects with overactive bladder. Urology 2010;75:62-8.
24. Herschorn S, Swift S, Guan Z, et al. Comparison of fesoterodine and tolterodine extended release for the treatment of overactive bladder: A head-to-head placebo-controlled trial. BJU Int 2010;105:58-66.
25. Rackley R, Weiss JP, Rovner ES, et al. Nighttime dosing with tolterodine reduces bladder-related nocturnal micturitions in patients with overactive bladder and nocturia. Urology 2006;67:731-6.
26. Johnson TM II, Jones K, Williford WO, et al. Changes in Nocturia from medical treatment of benign prostatic hyperplasia: Secondary analysis of the department of veterans affairs cooperative study trial. J Urol 2003;170:145-8. (Pubitemid 36734437)
27. Johnson TM II, Burrows PK, Kusek JW, et al. The effect of doxazosin, finasteride and combination therapy on nocturia in men with benign prostatic hyperplasia. J Urol 2007;178:2045-51. (Pubitemid 47538592)
28. Koseoglu H, et al. Nocturnal polyuria in patients with lower urinary tract symptoms and response to alpha-blocker therapy. Urology 2006;67:1188-92. (Pubitemid 43818069)
29. Speakman M. Efficacy and safety of Tamsulosin OCAS. BJU Int 2006;98:13-7. (Pubitemid 44423031)
30. Kaplan SA, Roehrborn CG, Rovner ES, et al. Tolterodine and Tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder. A randomized controlled trial. JAMA 2006;296:2319-28. (Pubitemid 44749359)
31. Bruskewitz RC, Larsen EH, Madsen PO, et al. 3-Year follow-up of urinary symptoms after transurethral resection of the prostate. J Urol 1986;136:613.
32. Cai T, Gardener N, Abraham L, et al. Impact of surgical treatment on nocturia in men with benign prostatic obstruction. BJU Int 2006;98:799-805. (Pubitemid 44368028)
33. Yoshimura K, Ohara H, Ichioka K, et al. Nocturia and benign prostatic hyperplasia. Urology 2003;61:786-90. (Pubitemid 36384974)
34. Andersson K-E. The pharmacological treatment of nocturia. BJU Int 2002;90:25-7. (Pubitemid 35417391)
35. Oelke M, Bachmann A, Descazeaud M, et al. EAU 2010 Guidelines on Conservative Treatment of Non-neurogenic Male LUTS.
36. van Kerrebroeck P, Rezapour M, Carteesse A, et al. Desmopressin in the treatment of nocturia - A double-blind, placebo-controlled study. Eur Urol 2007;52:221-9. (Pubitemid 46803012)
37. Weiss JP, Yea C, Nathadwarawala M, et al. Novel non-peptide pharmacologic therapy for nocturia in men. J. Urol 2010;183(4): Supplement, page e589-90.
38. Stanley N. The physiology of sleep and the impact of ageing. Eur Urol Suppl 2005;3:17-23. (Pubitemid 40353663)
39. Tikkinen KAO, Auvinen A, Johnson TM II, et al. A systematic evaluation of factors associated with nocturia - The population-based FINNO study. Am J Epidemiol 2009;170:361-8.
40. Ancoli-Israel S, Bliwise DL, Norgaard JP. The effect of nocturia on sleep. Sleep Med Rev 2011;15(2): 91-7. (Epub 2010 June 8) DOI: 10.1016/j.smrv.2010.03.002.